{"name":"Hospices Civils de Lyon","slug":"hospices-civils-de-lyon","ticker":"","exchange":"","domain":"chu-lyon.fr","description":"","hq":"Lyon","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":28,"colorKey":"oncology","drugs":[{"name":"urine test","genericName":"urine test","slug":"urine-test","indication":"Other","status":"phase_2"},{"name":"Axillary block anesthesia with Ropivacaine and Lidocaine","genericName":"Axillary block anesthesia with Ropivacaine and Lidocaine","slug":"axillary-block-anesthesia-with-ropivacaine-and-lidocaine","indication":"Other","status":"phase_1"},{"name":"Genetic and immunology tests","genericName":"Genetic and immunology tests","slug":"genetic-and-immunology-tests","indication":"Other","status":"phase_2"},{"name":"PCV chemotherapy","genericName":"PCV chemotherapy","slug":"pcv-chemotherapy","indication":"Recurrent or progressive glioblastoma","status":"phase_3"},{"name":"Radiotherapy and PCV chemotherapy","genericName":"Radiotherapy and PCV chemotherapy","slug":"radiotherapy-and-pcv-chemotherapy","indication":"Glioblastoma or high-grade glioma (Phase 3 trial context)","status":"phase_3"},{"name":"Registry","genericName":"Registry","slug":"registry","indication":"Other","status":"phase_2"},{"name":"Tocofersolan and tocopherol alpha","genericName":"Tocofersolan and tocopherol alpha","slug":"tocofersolan-and-tocopherol-alpha","indication":"Prevention of oxidative stress","status":"phase_3"},{"name":"blood sample","genericName":"blood sample","slug":"blood-sample","indication":"Other","status":"marketed"},{"name":"tocopherol alpha","genericName":"tocopherol alpha","slug":"tocopherol-alpha","indication":"Other","status":"marketed"},{"name":"A nasal swab","genericName":"A nasal swab","slug":"a-nasal-swab","indication":"Other","status":"phase_1"},{"name":"Biocollection","genericName":"Biocollection","slug":"biocollection","indication":"Other","status":"phase_2"},{"name":"Blood taken","genericName":"Blood taken","slug":"blood-taken","indication":"Diagnosis and monitoring of various health conditions","status":"phase_2"},{"name":"Blood test at D0","genericName":"Blood test at D0","slug":"blood-test-at-d0","indication":"Other","status":"phase_1"},{"name":"CFTR modulators","genericName":"CFTR modulators","slug":"cftr-modulators","indication":"Cystic fibrosis","status":"phase_2"},{"name":"CLARA","genericName":"CLARA","slug":"clara","indication":"Other","status":"marketed"},{"name":"Cabozantinib group","genericName":"Cabozantinib group","slug":"cabozantinib-group","indication":"Other","status":"marketed"},{"name":"Ciclosprin A","genericName":"Ciclosprin A","slug":"ciclosprin-a","indication":"Prevention of organ rejection in transplant patients","status":"phase_2"},{"name":"Collection of a lock of hair","genericName":"Collection of a lock of hair","slug":"collection-of-a-lock-of-hair","indication":"Other","status":"phase_1"},{"name":"Glucose 5% (placebo)","genericName":"Glucose 5% (placebo)","slug":"glucose-5-placebo","indication":"Placebo control in phase 3 clinical trial (specific indication unknown)","status":"phase_3"},{"name":"Iohexol renal clearance measurement","genericName":"Iohexol renal clearance measurement","slug":"iohexol-renal-clearance-measurement","indication":"Other","status":"phase_1"},{"name":"Monthly bolus of cholecalciferol per os","genericName":"Monthly bolus of cholecalciferol per os","slug":"monthly-bolus-of-cholecalciferol-per-os","indication":"Vitamin D deficiency prevention and treatment","status":"phase_3"},{"name":"Placebo of Indapamide (P2)","genericName":"Placebo of Indapamide (P2)","slug":"placebo-of-indapamide-p2","indication":"Other","status":"marketed"},{"name":"Placebo of Perindopril (P1)","genericName":"Placebo of Perindopril (P1)","slug":"placebo-of-perindopril-p1","indication":"Other","status":"marketed"},{"name":"Stool simple","genericName":"Stool simple","slug":"stool-simple","indication":"Other","status":"phase_1"},{"name":"Urine sampling","genericName":"Urine sampling","slug":"urine-sampling","indication":"Other","status":"phase_2"},{"name":"parenteral nutrition","genericName":"parenteral nutrition","slug":"parenteral-nutrition","indication":"Nutritional support in patients unable to tolerate oral or enteral feeding","status":"marketed"},{"name":"pirfenidone and nintedanib","genericName":"pirfenidone and nintedanib","slug":"pirfenidone-and-nintedanib","indication":"Other","status":"marketed"},{"name":"somatostatin infusion","genericName":"somatostatin infusion","slug":"somatostatin-infusion","indication":"Acute variceal bleeding (esophageal or gastric varices)","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":12,"colorKey":"immunology","drugs":[{"name":"Administration of a PET radiotracer","genericName":"Administration of a PET radiotracer","slug":"administration-of-a-pet-radiotracer","indication":"Diagnosis of various diseases, including cancer, neurological disorders, and cardiovascular conditions","status":"phase_2"},{"name":"Alkylating-based chemotherapy","genericName":"Alkylating-based chemotherapy","slug":"alkylating-based-chemotherapy","indication":"Various cancers","status":"phase_1"},{"name":"CTC detection","genericName":"CTC detection","slug":"ctc-detection","indication":"Cancer monitoring and prognosis assessment across multiple solid tumors","status":"phase_2"},{"name":"PSA dosage","genericName":"PSA dosage","slug":"psa-dosage","indication":"Prostate cancer screening and monitoring","status":"phase_3"},{"name":"Biological analyses","genericName":"Biological analyses","slug":"biological-analyses","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_2"},{"name":"Biological analysis","genericName":"Biological analysis","slug":"biological-analysis","indication":"Metastatic non-small cell lung cancer, PD-L1 positive","status":"phase_2"},{"name":"Biological samplings","genericName":"Biological samplings","slug":"biological-samplings","indication":"Monitoring of disease progression in cancer patients","status":"phase_2"},{"name":"Carboplatin-Taxol-Radiotherapy","genericName":"Carboplatin-Taxol-Radiotherapy","slug":"carboplatin-taxol-radiotherapy","indication":"Advanced ovarian cancer","status":"phase_2"},{"name":"Cisplatin-Gemzar","genericName":"Cisplatin-Gemzar","slug":"cisplatin-gemzar","indication":"Advanced ovarian cancer","status":"phase_2"},{"name":"Cisplatin-Navelbine-Radiotherapy","genericName":"Cisplatin-Navelbine-Radiotherapy","slug":"cisplatin-navelbine-radiotherapy","indication":"Non-small cell lung cancer, Small cell lung cancer, Ovarian cancer","status":"phase_2"},{"name":"DARATUMUMAB (DARZALEX®)","genericName":"DARATUMUMAB (DARZALEX®)","slug":"daratumumab-darzalex","indication":"Multiple myeloma (newly diagnosed)","status":"marketed"},{"name":"Pharmacokinetics, Dosage of Niraparib","genericName":"Pharmacokinetics, Dosage of Niraparib","slug":"pharmacokinetics-dosage-of-niraparib","indication":"Ovarian cancer (platinum-sensitive recurrent, BRCA-mutated, and homologous recombination deficient)","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"cardiovascular","drugs":[{"name":"Culture of removed prosthesis using DTT","genericName":"Culture of removed prosthesis using DTT","slug":"culture-of-removed-prosthesis-using-dtt","indication":"Diagnosis of prosthetic joint infection (PJI)","status":"phase_2"},{"name":"ribavirin with adaptation dose","genericName":"ribavirin with adaptation dose","slug":"ribavirin-with-adaptation-dose","indication":"Chronic hepatitis C","status":"phase_3"},{"name":"Antifungal treatment","genericName":"Antifungal treatment","slug":"antifungal-treatment","indication":"Fungal infections (specific indication depends on formulation and active ingredient)","status":"marketed"},{"name":"Direct-acting antiviral therapy","genericName":"Direct-acting antiviral therapy","slug":"direct-acting-antiviral-therapy","indication":"Hepatitis C","status":"phase_2"},{"name":"Peg-interferon alpha 2a and ribavin","genericName":"Peg-interferon alpha 2a and ribavin","slug":"peg-interferon-alpha-2a-and-ribavin","indication":"Chronic hepatitis C infection","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"infectious","drugs":[{"name":"Injection of Cyclosporin","genericName":"Injection of Cyclosporin","slug":"injection-of-cyclosporin","indication":"Prevention of organ rejection in transplant recipients","status":"phase_3"},{"name":"Corticosteroid boluses Methylprednisolone","genericName":"Corticosteroid boluses Methylprednisolone","slug":"corticosteroid-boluses-methylprednisolone","indication":"Acute exacerbations of multiple sclerosis","status":"phase_3"},{"name":"Daily dose of cholecalciferol per os","genericName":"Daily dose of cholecalciferol per os","slug":"daily-dose-of-cholecalciferol-per-os","indication":"Vitamin D deficiency","status":"phase_3"},{"name":"PRIVIGEN (CSL Behring)","genericName":"PRIVIGEN (CSL Behring)","slug":"privigen-csl-behring","indication":"Primary immunodeficiency syndromes","status":"marketed"},{"name":"ciclosporine","genericName":"ciclosporine","slug":"ciclosporine","indication":"Kawasaki's disease","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"respiratory","drugs":[{"name":"BPAN Patients","genericName":"BPAN Patients","slug":"bpan-patients","indication":"Treatment of BPAN (Beta-Propeller Protein-Associated Neurodegeneration)","status":"phase_2"},{"name":"Lévétiracetam","genericName":"Lévétiracetam","slug":"l-v-tiracetam","indication":"Epilepsy (adjunctive therapy for partial-onset seizures)","status":"phase_3"},{"name":"Midazolam oral intake","genericName":"Midazolam oral intake","slug":"midazolam-oral-intake","indication":"Procedural sedation and anxiolysis","status":"phase_3"},{"name":"Vayarin®, supplementation of n-3 PUFA","genericName":"Vayarin®, supplementation of n-3 PUFA","slug":"vayarin-supplementation-of-n-3-pufa","indication":"Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"rare","drugs":[{"name":"CELSIOR® group","genericName":"CELSIOR® group","slug":"celsior-group","indication":"Hypoglycemia for prevention in patients with type 1 diabetes","status":"phase_2"},{"name":"Gutron® treatment","genericName":"Gutron® treatment","slug":"gutron-treatment","indication":"Hypercholesterolemia","status":"phase_2"},{"name":"keto-analogs","genericName":"keto-analogs","slug":"keto-analogs","indication":"Type 2 diabetes treatment","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"Indapamide (T2)","genericName":"Indapamide (T2)","slug":"indapamide-t2","indication":"Hypertension","status":"marketed"},{"name":"Perindopril (T1)","genericName":"Perindopril (T1)","slug":"perindopril-t1","indication":"Hypertension","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"metabolic","drugs":[{"name":"Locoregional anesthesia","genericName":"Locoregional anesthesia","slug":"locoregional-anesthesia","indication":"Local or regional anesthesia for surgical procedures","status":"phase_3"},{"name":"Placebo followed by zicotinide","genericName":"Placebo followed by zicotinide","slug":"placebo-followed-by-zicotinide","indication":"Chronic pain in patients intolerant to or refractory to other analgesics (intrathecal administration)","status":"phase_3"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"ophthalmology","drugs":[{"name":"pirfenidone or nintedanib","genericName":"pirfenidone or nintedanib","slug":"pirfenidone-or-nintedanib","indication":"Idiopathic pulmonary fibrosis (IPF)","status":"marketed"}]}],"pipeline":[{"name":"urine test","genericName":"urine test","slug":"urine-test","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Administration of a PET radiotracer","genericName":"Administration of a PET radiotracer","slug":"administration-of-a-pet-radiotracer","phase":"phase_2","mechanism":"This PET radiotracer is used to visualize and diagnose various diseases by emitting radiation that can be detected by a PET scanner.","indications":["Diagnosis of various diseases, including cancer, neurological disorders, and cardiovascular conditions"],"catalyst":""},{"name":"Alkylating-based chemotherapy","genericName":"Alkylating-based chemotherapy","slug":"alkylating-based-chemotherapy","phase":"phase_1","mechanism":"Alkylating agent that interferes with DNA replication","indications":["Various cancers"],"catalyst":""},{"name":"Axillary block anesthesia with Ropivacaine and Lidocaine","genericName":"Axillary block anesthesia with Ropivacaine and Lidocaine","slug":"axillary-block-anesthesia-with-ropivacaine-and-lidocaine","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CTC detection","genericName":"CTC detection","slug":"ctc-detection","phase":"phase_2","mechanism":"CTC detection is a diagnostic technology that identifies and isolates circulating tumor cells (CTCs) from patient blood samples to enable cancer monitoring and prognosis assessment.","indications":["Cancer monitoring and prognosis assessment across multiple solid tumors","Treatment response evaluation in cancer patients"],"catalyst":""},{"name":"Culture of removed prosthesis using DTT","genericName":"Culture of removed prosthesis using DTT","slug":"culture-of-removed-prosthesis-using-dtt","phase":"phase_2","mechanism":"This is a diagnostic/microbiological procedure that cultures removed prosthetic material treated with dithiothreitol (DTT) to identify bacterial biofilms and infections.","indications":["Diagnosis of prosthetic joint infection (PJI)","Identification of biofilm-associated infections on removed prosthetic devices"],"catalyst":""},{"name":"Genetic and immunology tests","genericName":"Genetic and immunology tests","slug":"genetic-and-immunology-tests","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Indapamide (T2)","genericName":"Indapamide (T2)","slug":"indapamide-t2","phase":"marketed","mechanism":"Indapamide is a thiazide-like diuretic that inhibits sodium reabsorption in the distal convoluted tubule of the kidney, reducing blood volume and lowering blood pressure.","indications":["Hypertension","Edema associated with congestive heart failure"],"catalyst":""},{"name":"Injection of Cyclosporin","genericName":"Injection of Cyclosporin","slug":"injection-of-cyclosporin","phase":"phase_3","mechanism":"Cyclosporin is a calcineurin inhibitor that suppresses T-cell activation by blocking the transcription of pro-inflammatory cytokines.","indications":["Prevention of organ rejection in transplant recipients","Severe autoimmune conditions (e.g., severe rheumatoid arthritis, severe atopic dermatitis)"],"catalyst":""},{"name":"PCV chemotherapy","genericName":"PCV chemotherapy","slug":"pcv-chemotherapy","phase":"phase_3","mechanism":"PCV is a chemotherapy regimen combining procarbazine, lomustine (CCNU), and vincristine to disrupt cancer cell DNA and microtubule function.","indications":["Recurrent or progressive glioblastoma","Anaplastic oligodendroglioma","Low-grade gliomas"],"catalyst":""},{"name":"PSA dosage","genericName":"PSA dosage","slug":"psa-dosage","phase":"phase_3","mechanism":"PSA dosage is used to measure the level of prostate-specific antigen in the blood, which can help diagnose and monitor prostate cancer.","indications":["Prostate cancer screening and monitoring"],"catalyst":""},{"name":"Radiotherapy and PCV chemotherapy","genericName":"Radiotherapy and PCV chemotherapy","slug":"radiotherapy-and-pcv-chemotherapy","phase":"phase_3","mechanism":"This combination uses ionizing radiation to destroy tumor cells directly while chemotherapy with procarbazine, lomustine, and vincristine (PCV) enhances cell death through DNA damage and mitotic inhibition.","indications":["Glioblastoma or high-grade glioma (Phase 3 trial context)"],"catalyst":""},{"name":"Registry","genericName":"Registry","slug":"registry","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Tocofersolan and tocopherol alpha","genericName":"Tocofersolan and tocopherol alpha","slug":"tocofersolan-and-tocopherol-alpha","phase":"phase_3","mechanism":"Tocofersolan and tocopherol alpha work together to provide antioxidant properties.","indications":["Prevention of oxidative stress"],"catalyst":""},{"name":"blood sample","genericName":"blood sample","slug":"blood-sample","phase":"marketed","mechanism":"A blood sample is a diagnostic specimen collected for laboratory analysis to assess health status, detect diseases, or monitor treatment.","indications":[],"catalyst":""},{"name":"ribavirin with adaptation dose","genericName":"ribavirin with adaptation dose","slug":"ribavirin-with-adaptation-dose","phase":"phase_3","mechanism":"Ribavirin is an antiviral medication that works by inhibiting viral RNA synthesis.","indications":["Chronic hepatitis C","Respiratory syncytial virus infection"],"catalyst":""},{"name":"tocopherol alpha","genericName":"tocopherol alpha","slug":"tocopherol-alpha","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"A nasal swab","genericName":"A nasal swab","slug":"a-nasal-swab","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Antifungal treatment","genericName":"Antifungal treatment","slug":"antifungal-treatment","phase":"marketed","mechanism":"Antifungal treatments work by disrupting fungal cell wall or membrane integrity, or inhibiting essential fungal enzymes, thereby killing or stopping the growth of fungal organisms.","indications":["Fungal infections (specific indication depends on formulation and active ingredient)"],"catalyst":""},{"name":"BPAN Patients","genericName":"BPAN Patients","slug":"bpan-patients","phase":"phase_2","mechanism":"BPAN Patients is a treatment for a rare genetic disorder.","indications":["Treatment of BPAN (Beta-Propeller Protein-Associated Neurodegeneration)"],"catalyst":""},{"name":"Biocollection","genericName":"Biocollection","slug":"biocollection","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Biological analyses","genericName":"Biological analyses","slug":"biological-analyses","phase":"phase_2","mechanism":"This drug targets the PD-1 receptor to modulate the immune system.","indications":["Non-small cell lung cancer, PD-L1 positive","Melanoma"],"catalyst":""},{"name":"Biological analysis","genericName":"Biological analysis","slug":"biological-analysis","phase":"phase_2","mechanism":"This drug targets the PD-1 receptor to modulate the immune response.","indications":["Metastatic non-small cell lung cancer, PD-L1 positive","Metastatic melanoma"],"catalyst":""},{"name":"Biological samplings","genericName":"Biological samplings","slug":"biological-samplings","phase":"phase_2","mechanism":"Biological samplings involve the collection and analysis of biological samples to understand disease mechanisms and monitor treatment response.","indications":["Monitoring of disease progression in cancer patients"],"catalyst":""},{"name":"Blood taken","genericName":"Blood taken","slug":"blood-taken","phase":"phase_2","mechanism":"Blood taken is used to diagnose and monitor various health conditions.","indications":["Diagnosis and monitoring of various health conditions"],"catalyst":""},{"name":"Blood test at D0","genericName":"Blood test at D0","slug":"blood-test-at-d0","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"CELSIOR® group","genericName":"CELSIOR® group","slug":"celsior-group","phase":"phase_2","mechanism":"CELSEOR is a glucagon receptor agonist.","indications":["Hypoglycemia for prevention in patients with type 1 diabetes"],"catalyst":""},{"name":"CFTR modulators","genericName":"CFTR modulators","slug":"cftr-modulators","phase":"phase_2","mechanism":"CFTR modulators work by modifying the cystic fibrosis transmembrane conductance regulator protein to restore normal chloride ion transport across epithelial cell membranes.","indications":["Cystic fibrosis","Cystic fibrosis with a F508del mutation"],"catalyst":""},{"name":"CLARA","genericName":"CLARA","slug":"clara","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cabozantinib group","genericName":"Cabozantinib group","slug":"cabozantinib-group","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Carboplatin-Taxol-Radiotherapy","genericName":"Carboplatin-Taxol-Radiotherapy","slug":"carboplatin-taxol-radiotherapy","phase":"phase_2","mechanism":"Carboplatin is a platinum-based chemotherapy drug that interferes with DNA replication, while Taxol (paclitaxel) is a microtubule inhibitor that prevents cell division. Radiotherapy uses ionizing radiation to kill cancer cells.","indications":["Advanced ovarian cancer","Small cell lung cancer"],"catalyst":""},{"name":"Ciclosprin A","genericName":"Ciclosprin A","slug":"ciclosprin-a","phase":"phase_2","mechanism":"Ciclosprin A is an immunosuppressive agent that inhibits the activity of T cells.","indications":["Prevention of organ rejection in transplant patients"],"catalyst":""},{"name":"Cisplatin-Gemzar","genericName":"Cisplatin-Gemzar","slug":"cisplatin-gemzar","phase":"phase_2","mechanism":"Cisplatin-Gemzar works by inhibiting DNA replication and interfering with the synthesis of DNA and RNA, ultimately leading to cell death.","indications":["Advanced ovarian cancer","Pancreatic cancer"],"catalyst":""},{"name":"Cisplatin-Navelbine-Radiotherapy","genericName":"Cisplatin-Navelbine-Radiotherapy","slug":"cisplatin-navelbine-radiotherapy","phase":"phase_2","mechanism":"Cisplatin works by crosslinking DNA, causing cell death, while Navelbine inhibits microtubule formation, disrupting cell division.","indications":["Non-small cell lung cancer, Small cell lung cancer, Ovarian cancer"],"catalyst":""},{"name":"Collection of a lock of hair","genericName":"Collection of a lock of hair","slug":"collection-of-a-lock-of-hair","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Corticosteroid boluses Methylprednisolone","genericName":"Corticosteroid boluses Methylprednisolone","slug":"corticosteroid-boluses-methylprednisolone","phase":"phase_3","mechanism":"Methylprednisolone is a synthetic corticosteroid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.","indications":["Acute exacerbations of multiple sclerosis","Severe autoimmune and inflammatory conditions requiring rapid immunosuppression","Acute transplant rejection"],"catalyst":""},{"name":"DARATUMUMAB (DARZALEX®)","genericName":"DARATUMUMAB (DARZALEX®)","slug":"daratumumab-darzalex","phase":"marketed","mechanism":"Daratumumab is a monoclonal antibody that binds to CD38 on the surface of multiple myeloma cells, triggering their destruction through multiple immune mechanisms.","indications":["Multiple myeloma (newly diagnosed)","Multiple myeloma (relapsed or refractory)","Light chain multiple myeloma"],"catalyst":""},{"name":"Daily dose of cholecalciferol per os","genericName":"Daily dose of cholecalciferol per os","slug":"daily-dose-of-cholecalciferol-per-os","phase":"phase_3","mechanism":"Cholecalciferol (vitamin D3) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function.","indications":["Vitamin D deficiency","Osteoporosis prevention or treatment","Immune function support"],"catalyst":""},{"name":"Direct-acting antiviral therapy","genericName":"Direct-acting antiviral therapy","slug":"direct-acting-antiviral-therapy","phase":"phase_2","mechanism":"Direct-acting antiviral therapy targets viral replication by inhibiting viral enzymes.","indications":["Hepatitis C","Hepatitis B"],"catalyst":""},{"name":"Glucose 5% (placebo)","genericName":"Glucose 5% (placebo)","slug":"glucose-5-placebo","phase":"phase_3","mechanism":"Glucose 5% solution serves as an inert placebo control with no active pharmacological mechanism.","indications":["Placebo control in phase 3 clinical trial (specific indication unknown)"],"catalyst":""},{"name":"Gutron® treatment","genericName":"Gutron® treatment","slug":"gutron-treatment","phase":"phase_2","mechanism":"Gutron treatment works by inhibiting the reabsorption of bile acids in the ileum.","indications":["Hypercholesterolemia"],"catalyst":""},{"name":"Iohexol renal clearance measurement","genericName":"Iohexol renal clearance measurement","slug":"iohexol-renal-clearance-measurement","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Locoregional anesthesia","genericName":"Locoregional anesthesia","slug":"locoregional-anesthesia","phase":"phase_3","mechanism":"Locoregional anesthesia blocks nerve conduction locally to produce reversible loss of sensation in a specific anatomical region without affecting consciousness.","indications":["Local or regional anesthesia for surgical procedures","Pain management and analgesia in clinical settings"],"catalyst":""},{"name":"Lévétiracetam","genericName":"Lévétiracetam","slug":"l-v-tiracetam","phase":"phase_3","mechanism":"Levetiracetam reduces neuronal excitability by binding to synaptic vesicle protein SV2A, thereby modulating neurotransmitter release and preventing seizure propagation.","indications":["Epilepsy (adjunctive therapy for partial-onset seizures)","Epilepsy (adjunctive therapy for myoclonic seizures)","Epilepsy (adjunctive therapy for primary generalized tonic-clonic seizures)"],"catalyst":""},{"name":"Midazolam oral intake","genericName":"Midazolam oral intake","slug":"midazolam-oral-intake","phase":"phase_3","mechanism":"Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation and anxiolysis.","indications":["Procedural sedation and anxiolysis","Preoperative anxiety management","Acute anxiety disorders"],"catalyst":""},{"name":"Monthly bolus of cholecalciferol per os","genericName":"Monthly bolus of cholecalciferol per os","slug":"monthly-bolus-of-cholecalciferol-per-os","phase":"phase_3","mechanism":"Cholecalciferol (vitamin D3) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function.","indications":["Vitamin D deficiency prevention and treatment","Bone health and osteoporosis prevention"],"catalyst":""},{"name":"PRIVIGEN (CSL Behring)","genericName":"PRIVIGEN (CSL Behring)","slug":"privigen-csl-behring","phase":"marketed","mechanism":"PRIVIGEN is an intravenous immunoglobulin (IVIg) that provides passive immunity by supplying pooled human antibodies to modulate immune responses and replace deficient immunoglobulins.","indications":["Primary immunodeficiency syndromes","Secondary immunodeficiency in hematologic malignancies","Chronic inflammatory demyelinating polyneuropathy (CIDP)","Multifocal motor neuropathy (MMN)","Immune thrombocytopenia (ITP)"],"catalyst":""},{"name":"Peg-interferon alpha 2a and ribavin","genericName":"Peg-interferon alpha 2a and ribavin","slug":"peg-interferon-alpha-2a-and-ribavin","phase":"phase_3","mechanism":"Peg-interferon alpha-2a activates innate immune responses against viral infection, while ribavirin inhibits viral RNA synthesis, together targeting hepatitis C virus replication.","indications":["Chronic hepatitis C infection"],"catalyst":""},{"name":"Perindopril (T1)","genericName":"Perindopril (T1)","slug":"perindopril-t1","phase":"marketed","mechanism":"Perindopril inhibits angiotensin-converting enzyme (ACE), reducing the formation of angiotensin II and lowering blood pressure.","indications":["Hypertension","Heart failure","Post-myocardial infarction","Chronic kidney disease"],"catalyst":""},{"name":"Pharmacokinetics, Dosage of Niraparib","genericName":"Pharmacokinetics, Dosage of Niraparib","slug":"pharmacokinetics-dosage-of-niraparib","phase":"marketed","mechanism":"Niraparib inhibits poly(ADP-ribose) polymerase (PARP) enzymes, preventing DNA repair in cancer cells and leading to cell death.","indications":["Ovarian cancer (platinum-sensitive recurrent, BRCA-mutated, and homologous recombination deficient)","Metastatic breast cancer (BRCA-mutated)","Prostate cancer (BRCA-mutated, metastatic castration-resistant)"],"catalyst":""},{"name":"Placebo followed by zicotinide","genericName":"Placebo followed by zicotinide","slug":"placebo-followed-by-zicotinide","phase":"phase_3","mechanism":"Ziconotide is a selective N-type calcium channel blocker that reduces neuronal excitability and neurotransmitter release in the spinal cord to alleviate chronic pain.","indications":["Chronic pain in patients intolerant to or refractory to other analgesics (intrathecal administration)"],"catalyst":""},{"name":"Placebo of Indapamide (P2)","genericName":"Placebo of Indapamide (P2)","slug":"placebo-of-indapamide-p2","phase":"marketed","mechanism":"This is a placebo control with no active pharmacological mechanism.","indications":[],"catalyst":""},{"name":"Placebo of Perindopril (P1)","genericName":"Placebo of Perindopril (P1)","slug":"placebo-of-perindopril-p1","phase":"marketed","mechanism":"This is a placebo formulation with no active pharmacological mechanism.","indications":[],"catalyst":""},{"name":"Stool simple","genericName":"Stool simple","slug":"stool-simple","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Urine sampling","genericName":"Urine sampling","slug":"urine-sampling","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Vayarin®, supplementation of n-3 PUFA","genericName":"Vayarin®, supplementation of n-3 PUFA","slug":"vayarin-supplementation-of-n-3-pufa","phase":"phase_3","mechanism":"Vayarin® provides a targeted delivery of n-3 polyunsaturated fatty acids (PUFAs) to support brain health and function.","indications":["Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents"],"catalyst":""},{"name":"ciclosporine","genericName":"ciclosporine","slug":"ciclosporine","phase":"phase_3","mechanism":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","indications":["Kawasaki's disease","Keratoconjunctivitis sicca","Prevention of Cardiac Transplant Rejection","Prevention of Kidney Transplant Rejection","Prevention of Liver Transplant Rejection"],"catalyst":""},{"name":"keto-analogs","genericName":"keto-analogs","slug":"keto-analogs","phase":"phase_3","mechanism":"Keto-analogs are synthetic compounds that mimic the effects of ketone bodies, which are produced by the liver when it breaks down fat for energy.","indications":["Type 2 diabetes treatment"],"catalyst":""},{"name":"parenteral nutrition","genericName":"parenteral nutrition","slug":"parenteral-nutrition","phase":"marketed","mechanism":"Parenteral nutrition delivers a balanced mixture of carbohydrates, proteins, lipids, vitamins, and minerals intravenously to provide complete nutritional support when oral or enteral feeding is not possible.","indications":["Nutritional support in patients unable to tolerate oral or enteral feeding","Short bowel syndrome","Severe malabsorption disorders","Bowel obstruction or ileus","Critical illness with feeding intolerance"],"catalyst":""},{"name":"pirfenidone and nintedanib","genericName":"pirfenidone and nintedanib","slug":"pirfenidone-and-nintedanib","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"pirfenidone or nintedanib","genericName":"pirfenidone or nintedanib","slug":"pirfenidone-or-nintedanib","phase":"marketed","mechanism":"Pirfenidone and nintedanib are antifibrotic agents that reduce fibroblast proliferation and collagen deposition to slow lung fibrosis progression.","indications":["Idiopathic pulmonary fibrosis (IPF)"],"catalyst":""},{"name":"somatostatin infusion","genericName":"somatostatin infusion","slug":"somatostatin-infusion","phase":"phase_3","mechanism":"Somatostatin infusion activates somatostatin receptors on neuroendocrine and immune cells to inhibit hormone and cytokine secretion and reduce splanchnic blood flow.","indications":["Acute variceal bleeding (esophageal or gastric varices)","Gastrointestinal hemorrhage control"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxNaFZtRUtqTEVMdXBwcXNMbzUtdS1wbm9lTWhlYnhNQzlLRkg4NUsyYlk1Zi1QZGtuSEJ5ZVFhdDBDMnJtWDkyWXNaSXdhcUlpOW9ic19jNXVrTE1DemJLa0NJTGRkRUxEWm1FQXlFdDRIM0kyY3A0RzJMRmVBY1piUWx2V3hrN0ZOQXhEUEJjTEdxNTh1aHlZNnVkaElEMjVNb0pGMDd5WGI0cjBEVVZJN01obEhvaEUteVNFbDBDS1BCWE1ndGNoWWZRNWUtWVJGWnVDYTZIVmt6RUtqdUx6LUFWd2dPQzZkU0htUl9RV1pSR0JQTkRJUmFVOFNGNk1pdDJLdVhTckw2QVRVOC1HUGVpRVhnaUxlQ09KeTRPWGtoMkh1RVE?oc=5","date":"2025-02-04","type":"pipeline","source":"BioSpace","summary":"MITEM PHARMA Continues Its Mission to Protect the Interests of Patients Suffering From Rare and Lethal Diseases by Acquiring the FLISINT® Speciality from SANOFI - BioSpace","headline":"MITEM PHARMA Continues Its Mission to Protect the Interests of Patients Suffering From Rare and Lethal Diseases by Acqui","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5tSFJReTFjZS1XRnlyUEcyRXRDTFJYSE9ROVZlclNvTm9KQ1hUbTVBMlFMd08tTHBRaDhBMDhaaGFsZ2p6SDE5MTNrVDJ4ZWFIZjlHT2FaQ0JkRGNCR3Fj?oc=5","date":"2024-12-30","type":"pipeline","source":"Nature","summary":"Real-time monitoring by interferometric light microscopy of phage suspensions for personalised phage therapy - Nature","headline":"Real-time monitoring by interferometric light microscopy of phage suspensions for personalised phage therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9GUDl2ZkRPZ1pSZzl6YkxLSGNJZzE3bHhLdWxoSzJ6dkZEVF9Ed1k2ZDh4Z3RkUVV1ZWltUDA1MkhvYXZaMzJGcTZkSEg4Z2dHMmdDclVjVjVGWFkzakc4?oc=5","date":"2024-06-24","type":"pipeline","source":"Nature","summary":"Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B | Scientific Reports - Nature","headline":"Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE96emQxOXFpWWxQQ194dGZ5QWxvRzhLdG9rNVh2d01MNlNqeFdGNWR6ZndHbko0NnFQV3FrOGtLSGpfMFZCQUdxZ2pMOHFCZW9FV2gxd29NREpEcVBHSjduOWFyOTcwbTZOOUE?oc=5","date":"2024-04-24","type":"trial","source":"Neurology® Journals","summary":"Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABA - Neurology® Journals","headline":"Comparative Study of Paraneoplastic and Nonparaneoplastic Autoimmune Encephalitis With GABA - Neurology® Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBPOFJDT0J5ZUo3YlU2WllVclA5TVJBdVJTWEdRQUNkOW9FbHBkRFBUYklfZ1ZsUGQzbE1fMVRJNnBKWl9GaXRxWEZnQ1l2d2NmcUNmRjBvRm5XdGlIZVA1TU9MWFkwdkhVMWc?oc=5","date":"2023-12-24","type":"pipeline","source":"Neurology® Journals","summary":"Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis - Neurology® Journals","headline":"Prognostic Value of Persistent CSF Antibodies at 12 Months in Anti-NMDAR Encephalitis - Neurology® Journals","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE0zcHZVSk9BaFprQW16QnN2aG5QZGc0MXIzbzBBUmhCa1d3OG45aHJBYm9ILUpMS0RhSEhTcU9rN3A0emNxOFV5MW1SWHhkVEw4anJMejlOSUVpS1k?oc=5","date":"2023-04-12","type":"trial","source":"EurekAlert!","summary":"Targeting Phage Therapy 2023 final agenda, chairpersons, and speakers are released: 51+ communication, 125+ attendees, 30+ industrials - EurekAlert!","headline":"Targeting Phage Therapy 2023 final agenda, chairpersons, and speakers are released: 51+ communication, 125+ attendees, 3","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5haXQwRzhLWW50VnRRWjJneFctQS1BWHRZYmF2SGtQRzRCbHRWTFVTbjZwUmc3Z1JNQTNqMkZiSy13TmtUeG41QzEzSHdmOE03bld0enB1Y09lalZaYWxmcWVqTHdncno0bFAxYjF1NEhwX2dLeUFWSg?oc=5","date":"2022-12-27","type":"pipeline","source":"Springer Nature Link","summary":"Intraoperative extracorporeal blood purification therapy during major septic vascular surgery - Springer Nature Link","headline":"Intraoperative extracorporeal blood purification therapy during major septic vascular surgery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPUXlGTjlsU3MyODVBcUE2MXMtSEk3aXp4QWVNNHg3SzFwSG5pQl9wQUlCc1JXVmgzX1hHYjZ3R3IwUDVXWVIxZ2Jub0FRbTZENXVkbFpOeHcyeWNjdFRMQU1OaUhDX1BFVDJzdjc1VC11YmZzTlZyNTUwQmpvdmRaYmFHdXcyT053R1o0dGlCd2w4YldFbXNjVw?oc=5","date":"2022-08-15","type":"pipeline","source":"Renal and Urology News","summary":"Vitamin D, PTH Linked With Bone Decline in Older Men - Renal and Urology News","headline":"Vitamin D, PTH Linked With Bone Decline in Older Men","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9GOXpKQThieWlZa1gwYXhFTWZyZTZLMHBZZV95TU1BTzZ0ZlNwODI2RmVKNTR6SFZPX05Cb0VXcGdZdFNyN2M1RTRRVGZFY2d2OGNSRGNKTkgyTTdydTh3?oc=5","date":"2022-07-22","type":"pipeline","source":"Nature","summary":"Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection - Nature","headline":"Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOZ3BNNU1FU2pCR3NlVWJsaTkyVFFsM2JzWm9yVlkxM3doRDliTzB2V0FRYzJjWldKV0d1TWMyQzB6QjVtemJ3U3VQbFlxMmF1VVV4OG16QUpRVERkQzAwRHRIV1dLbDhWVWhfTXFJVmtMZVF0T2JkNHdXX3NndWJnb3ZPdkhvV2ZBWkdaLVFyU2lMSlk?oc=5","date":"2021-09-08","type":"pipeline","source":"Frontiers","summary":"Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes - Frontiers","headline":"Tele-pharmacy Anticoagulation Clinic During COVID-19 Pandemic: Patient Outcomes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxObmp1Qld1VFZTdDYxRUp5bnRGUnkxeTNubFZwRjhqRjB3Unl2eFFseVB3UXA5bTh2cjhhTE83X1F4Yl9WVVc0V1UxUzFEbG9OaVhmLTFQa01EamstR1RaVzFmUU5WT2lOWm9uMDNKNkJVU3dkWHZlUGt3TmhTYzg4NGRiNW9hNXB1dGQybA?oc=5","date":"2021-05-04","type":"pipeline","source":"Frontiers","summary":"Case Report: Arthroscopic “Debridement Antibiotics and Implant Retention” With Local Injection of Personalized Phage Therapy to Salvage a Relapsing Pseudomonas Aeruginosa Prosthetic Knee Infection - F","headline":"Case Report: Arthroscopic “Debridement Antibiotics and Implant Retention” With Local Injection of Personalized Phage The","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5qRmJ5UkZONHQ3aVhvVmg3TUZEakJOT1NXTG8yWmYzX0lEb1RkVWFpOTNCa1VZTUpiRURhdExCc1pTUnhIZlNfc1FIV0hHZ2pLQkhoTjVBSGdWbUVLbEJKT1FWeVhtRVZsNHRj?oc=5","date":"2021-02-05","type":"pipeline","source":"Wiley Online Library","summary":"Prevalence of low health literacy levels in decompensated heart failure compared with acute myocardial infarction patients - Wiley Online Library","headline":"Prevalence of low health literacy levels in decompensated heart failure compared with acute myocardial infarction patien","sentiment":"neutral"}],"patents":[],"drugCount":62,"phaseCounts":{"phase_2":21,"phase_1":7,"marketed":15,"phase_3":19},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}